Could a Parkinson's drug help ALS patients breathe easier?
NCT ID NCT05377424
Summary
This study is testing whether a drug called istradefylline, when combined with short periods of breathing low-oxygen air, can help people with ALS breathe more deeply. It involves 40 participants, including people with ALS and healthy adults, across four separate study visits. The goal is to see if this combination is safe and can temporarily improve breathing function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical and Translational Research Building
Gainesville, Florida, 32610, United States
-
UF Health Jacksonville
Jacksonville, Florida, 32209, United States
Conditions
Explore the condition pages connected to this study.